Advertisement

Topics

Fulton Ventures,LLC Company Profile

18:52 EST 10th December 2018 | BioPortfolio

Fulton Ventures is leading the creation of new business models for the biotech and pharma industry. Our simple approach focuses on two complimentary paths to improving the industry's business models: Create high-growth potential, adequately-diversified, appropriately-capitalized, clinical development portfolios
Build companies with high quality revenues and resulting excess cash flows to finance clinical development.

Location

7843 SE 40th street
mercer island
Washington
98040
United States of America

Contact

Email: samir@deodora.com


News Articles [345 Associated News Articles listed on BioPortfolio]

Startup Future Family rakes in $10M to expand subscription fertility service

Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.

Dr. Ana Tuya Fulton named fellow of American Geriatrics Society

(Care New England ) Ana Tuya Fulton, M.D., F.A.C.P., executive chief of geriatrics at Care New England and medical director of Integra Community Care Network, LLC, was recently inducted into the newes...

League raises fresh capital to grow employee health benefits platform

The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Ventu...

VelosBio closes $58mm Series A round

Oncology start-up VelosBio Inc. raised $58mm through its Series A round. Arix Bioscience and Sofinnova Ventures co-led and were joined by Pappas Ventures, Chiesi Ventures, and returning backers Takeda...

Neurotherapeutics discovery start-up System1 closes $25mm Series A round

System1 Biosciences Inc. (neurological and psychiatric disorder drug discovery using phenotypic screening) completed a $25mm Series A round co-led by CRV and Pfizer Ventures (both add board members). ...

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) raised $15.7mm in an oversubscribed Series A financing led by Hatteras Venture ...

Series B round brings $12.6mm to Gauss Surgical

Gauss Surgical Inc. (markets the Triton system for real-time blood loss monitoring during surgery and childbirth) raised $12.6mm in its Series B round from Providence Ventures (lead), Jump Capital, Pr...

Brain-machine interface start-up Paradromics brings in $7mm in seed funding

Paradromics Inc. (implantable brain-machine interface (BMI) technology) brought in $7mm in a seed financing round co-led by Arkitekt Ventures (adds a board member) and Synergy Ventures. It-Farm, Dolby...

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Aterra antibacterial hand wash [B4 Ventures LLC]

B4 Brands: Aterra Antibacterial Hand Soap

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Locating and eliminating feral swine from a large area of fragmented mixed forest and agriculture habitats in north-central USA.

Illinois is one of the US states where elimination of feral swine (Sus scrofa) was determined practical, as only a few isolated populations were established. A particularly important step towards fera...

Estimating and valuing the carbon release in scenarios of land-use and climate changes in a Brazilian coastal area.

Deforestation is a significant source of man-made carbon in the atmosphere, contributing to the greenhouse gas (GHG) effect. Although carbon releases are associated to the ecosystem functions of clima...

Persistent pulmonary hypertension alters epigenetic characteristics of endothelial nitric oxide synthase gene in a fetal lamb model.

Decreased expression of endothelial nitric oxide synthase (eNOS), a key mediator of perinatal transition, characterizes persistent pulmonary hypertension of the newborn (PPHN) in neonates and a fetal ...

"Yes, we know!" (Over)confidence in general knowledge among Austrian entrepreneurs.

Overconfidence has been reported to be a common bias among entrepreneurs and might be one cause of the high failure rates observed for new ventures. In this study, we investigate the overconfidence bi...

Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.

Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease characterized by fibroblast proliferation, extracellular matrix deposition, destruction of pulmonary alveolar architecture and vascula...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [562 Associated Companies listed on BioPortfolio]

Fulton Ventures,LLC

Fulton Ventures is leading the creation of new business models for the biotech and pharma industry. Our simple approach focuses on two complimentary paths to improving the industry's business models: ...

Fulton Innovation

A subsidiary of Alticor Corporation, Fulton Innovation is dedicated to commercializing new and innovative technologies that improve the way we live, work, and play. Fulton is work...

GE Ventures

GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...

Extraordinary Ventures, Inc.

Founded in 2007 by a group of concerned parents, Extraordinary Ventures (EV) is a 501(c)(3) enterprise that creates and operates a portfolio of self-sustaining small, local busine...

Archytas Ventures, LLC

Archytas Ventures is a private, opportunistic investment holding company with offices in New York and Los Angeles. Archytas Ventures provides strategic capital solutions to the em...

More Information about "Fulton Ventures,LLC" on BioPortfolio

We have published hundreds of Fulton Ventures,LLC news stories on BioPortfolio along with dozens of Fulton Ventures,LLC Clinical Trials and PubMed Articles about Fulton Ventures,LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fulton Ventures,LLC Companies in our database. You can also find out about relevant Fulton Ventures,LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record